Off-label, Low-Dose Naltrexone for Refractory Chronic Low Back Pain

Pain Med
May 2014
https://europepmc.org/article/med/24967470

Low‐dose naltrexone for the treatment of fibromyalgia: Findings of a small, randomized, double‐blind, placebo‐controlled, counterbalanced, crossover trial assessing daily pain levels

Arthritis & Rheumatology
28 January 2013
https://onlinelibrary.wiley.com/doi/full/10.1002/art.37734

Serious adverse events reported in placebo randomised controlled trials of oral naltrexone: a systematic review and meta-analysis


BMC Medicine
15 January  2019
https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-018-1242-0

 

Dr. Armin Schwarzbach, Infections in Cancer and Autoimmune Disorders. Presented by Markus Berger.

Low-Dose Naltrexone for Chronic Pain: Update and Systemic Review

Curr Pain Headache Rep
26 Aug 2020
https://pubmed.ncbi.nlm.nih.gov/32845365/


Purpose of review: The purpose of this review is to evaluate and explain our current understanding of the clinical use of low-dose naltrexone in the treatment of chronic pain.

Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels

Arthritis Rheum
February 2013
https://pubmed.ncbi.nlm.nih.gov/23359310/​​​​​​​

Low-Dose Naltrexone: An Inexpensive Medicine for Many Ills?

Medscape Medical News
11 Mar 2020
https://www.medscape.com/viewarticle/926611?src=WNL_trdalrt_201027_MSCPEDIT&uac=267476HJ&impID=2640101&f

Low-Dose Naltrexone Gaining Recognition as Chronic Pain Treatment

Pain News Network, 23 Nov 2020
https://www.painnewsnetwork.org/stories/2020/11/23/low-dose-naltrexone-gains-recognition-as-chronic-pain-treatment